Michelle Fay Cortez on Muck Rack

Michelle Fay Cortez

Verified
  • Senior Medical Reporter, and Asia Health Editor,, Bloomberg News
  • None, Bloomberg
East Coast United States, Washington, D.C.
As seen in: Bloomberg News, MSN, O Globo, UOL, Bloomberg Businessweek, Bloomberg Green Daily, Bloomberg Markets Magazine, ET Healthworld, The Economic Times, The Independent (UK), The Times of India and
Senior editor for Global Business at Bloomberg News, now coming to you from DC! Tips & tricks: mcortez@bloomberg.net.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michelle

Contact Michelle, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Ebola drugs should be limited to trials, WHO advisers say

|
By Michelle Fay Cortez , Gerry Smith 
| Killeen Daily Herald
Drugs in development to treat and prevent infections caused by the Ebola virus that's circulating in the Democratic Republic of Congo and Uganda should be given only as part of clinical trials, advisers to the World Health Organization said. That means people who are sick now, or are at risk of becoming sick after being exposed to them, may not get access.
Open in Who Shared View Duplicates (2) Issue with article?

Ebola drugs should be limited to trials, WHO advisers say

|
By Michelle Fay Cortez , Gerry Smith 
| Miami Herald
Drugs in development to treat and prevent infections caused by the Ebola virus that's circulating in the Democratic Republic of Congo and Uganda should be given only as part of clinical trials, advisers to the World Health Organization said. That means people who are sick now, or are at risk of becoming sick after being exposed to them, may not get access.
Open in Who Shared View Duplicates (32) Issue with article?

Ebola drugs should be limited to trials, WHO advisers say

|
By Michelle Fay Cortez , Gerry Smith 
| The Daily Gazette
Drugs in development to treat and prevent infections caused by the Ebola virus that’s circulating in the Democratic Republic of Congo and Uganda should be given only as part of clinical trials, advisers to the World Health Organization said. That means people who are sick now, or are at risk of becoming sick after being exposed to them, may not get access.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,711 licensed articles (2,502 Total)

Actions

Share this page

Get in touch with Michelle

Contact Michelle, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified